Rheumatic fever and long-term sequelae in children

Current Treatment Options in Cardiovascular Medicine

Volumn 4, Issue 4, 2002, Pages 309-319

  Saxena, Anita ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acute Rheumatic Fever; Kawasaki Disease; Mitral Regurgitation; Rheumatic Fever; Rheumatic Heart Disease

Indexed keywords

EID: 1642530578     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-002-0011-7     Document Type: Article

References (33)

1. Markowitz M, Kaplan E: Reappearance of rheumatic fever. Adv Pediatr 1989, 36:39–65.
2. Michaud C, Trejo-Gutierrez J, Cruz C, Pearson T: Rheumatic heart disease. In Disease Control Priorities in Developing Countries: A Summary. Edited by Jamison DT. Washington, D.C.: World Bank; 1993:221–232.
3. Padmawati S: Present status of rheumatic fever and rheumatic heart disease in India. Indian Heart J 1995, 47:395–398.
4. Grover A, Dhawan A, Iyenger SD, et al.: Epidemiology of rheumatic fever and rheumatic heart disease in a rural community in northern India. Bull World Health Organ 1993, 71:59–66.
5. Patel DC, Patel NI, Patel JD, Patel SD: Rheumatic fever and rheumatic heart disease in school children of Anand. J Assoc Physicians India 1986, 34:837–839.
6. Grover A, Vijayvergia R, Thingam ST: Burden of rheumatic and congenital heart disease in India: lowest estimate based on the 2001 census. Indian Heart J 2002, 54:104–107.
7. Rheumatic Fever and Rheumatic Heart Disease. WHO Technical Report series no. 764. Geneva: World Health Organization; 1988.
8. Jones TD: Diagnosis of rheumatic fever. JAMA 1944, 126:481–484.
9. Guidelines for the diagnosis of rheumatic fever: Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association [no authors listed]. JAMA 1992, 268:2069–2073.
10. Steinfeld L, Ritter S, Rappport H, Martinez E: Silent rheumatic mitral regurgitation unmarked by Doppler studies [abstract]. Circulation 1986, 74(suppl 11):385.
11. Veasy LG, Wiedmeier SE, Orsmond GS, et al.: Resurgence of acute rheumatic fever in the intermountain area of United States. N Engl J Med 1987, 316:421–427.
12. Vasan RS, Shrivastava S, Vijaykumar M, et al.: Echocardiographic evaluation of patients with or without acute rheumatic fever and rheumatic carditis. Circulation 1996, 94:73–82.
13. Albert DA, Harel L, Karrison T: The treatment of rheumatic carditis: a review and meta-analysis. Medicine 1995, 74:1–12.
14. Voss LM, Wilson NJ, Neutze JM, et al.: Intravenous immunoglobulins in acute rheumatic fever. A randomized controlled trial. Circulation 2001, 103:401–406.
15. Essop MR, Wisenbaugh T, Sareli P: Evidence against a myocardial factor as the cause of left ventricular dilatation in active rheumatic carditis. J Am Coll Cardiol 1993, 22:826–829.
16. BarlowJB, Marcus RH, Pocock WA, et al.: Mechanisms and management of heart failure in active rheumatic carditis. South Afr Med J 1998, 78:181–186. This study conclusively proves that valvular regurgitation, and not myocarditis, is the main cause of congestive heart failure in active rheumatic carditis.
17. Gentles TL, Colan SD, Wilson NJ, et al.: Left ventricular mechanics during and after acute rheumatic fever: contractile dysfunction is closely related to valve regurgitation. J Am Coll Cardiol 2001, 37:201–207.
18. Al Kasab S, Al Fagih MR, Shahid M, et al.: Valve surgery in acute rheumatic heart disease. One to four year follow up. Chest 1988, 94:830–833.
19. Skoularigis J, Sinovich V, Joubert G, Sareli P: Evaluation of the long term results of mitral valve repair in 254 young patients with rheumatic mitral regurgitation. Circulation 1994,90(part2):167–174.
20. Vasan RS, Selvaraj N: Natural history of acute rheumatic fever. In Rheumatic Fever. Edited by Narula J et al. Washington D.C.: American Registry of Pathology. Armed Forces Institute of Pathology; 1999:347–358. Describes the literature on the natural history of rheumatic fever in detail.
21. Tompkins DG, Boxerbaum B, Liebman J: Long term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 1972, 45:543–551.
22. Majeed HA, Bhatnagar S, Yousof AM, et al.: Acute rheumatic fever and the evolution of rheumatic heart disease: a prospective 12-year follow up report. J Clin Epidemiol 1992, 45:871–875.
23. Lue HC, Chen CL, Wei H, et al.: The natural history of rheumatic fever and rheumatic heart disease in the orient. Jap Heart J 1979, 20:237–252.
24. Natural history of rheumatic fever and rheumatic heart disease. Ten-year report of a cooperative clinical trial of ACTH, cortisone, and aspirin [no authors listed]. Circulation 1965, 32:457–476.
25. Stollerman GH, Ruroff JH: Prophylaxis against group A streptococcal infections in rheumatic fever patients. Use of new repository penicillin preparation. JAMA 1952, 150:1571–1575.
26. WHO principal investigations: WHO program for the prevention of rheumatic fever and rheumatic heart disease in 16 developing countries. Report from the phase I study. Bull WHO 1992, 70:213–218.
27. Dajani AS, Bisno AL, Chunh KJ, et al.: Prevention of rheumatic fever: a statement for health professionals by the committee on rheumatic fever, endocarditis and Kawasaki disease, of the council on Cardiovascular Disease in the Young, The American Heart Association. Pediatr Infect Dis J 1989, 8:263–266.
28. Padmawati S, Gupta V, Prakash K, Sharma KB: Penicillin for rheumatic fever prophylaxis: 3-weekly or 4-weekly schedule. J Assoc Physicians India 1987, 35:753–755.
29. Lue HC, Wu MH, Wang JK, et al.: Long term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J Pediatr 1994, 175:812–816.
30. Meira ZM, Mota CD, Tonelli E, et al.: Evaluation of secondary prophylaxis based on benzathine penicillin G for rheumatic fever in children. J Pediatr 1993, 123:156–158.
31. Berrios X, del Campo E, Guzman B, Bisno AL: Discontinuing rheumatic fever prophylaxis in selected adolescents and young adults: a prospective study. Ann Intern Med 1993, 118:401–406.
32. Allergic reaction to long-term penicillin prophylaxis for rheumatic fever. International Rheumatic Fever Study Group [no authors listed]. Lancet 1991, 337:1308–1310.
33. MedinaE, Chhatwal GS: The potential for vaccine development against rheumatic fever. Indian Heart J 2002, 54:93–98. A perspective study on the various issues related to the development of a streptococcal vaccine.